Bionano Genomics, Inc. (NASDAQ:BNGO) headquartered in San Diego, will host a conference call for the investment community to discuss the 3Q20 financial results on 12th November 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.bionanogenomics.com
To participate on the live call, please dial 877-407-0784 U.S. or 201-689-8560 (International), and the passcode is 13712129
Earnings Expectation
Bionano Genomics, Inc. is expected to report third quarter earnings results, after market close, on Thursday 12th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.05 per share from revenue of $ 2.07 million. Looking ahead, the full year loss are expected at $ 0.37 per share on the revenues of $ 7.96 million.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 1.90 million ~ $ 2.30 million
Click Here For More Historical Outlooks Of Bionano Genomics, Inc.
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics.
